Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease
for Diabetic Kidney Disease (DKD)
51 locations incl. Huntsville
Sponsor: Regeneron Pharmaceuticals
Sex: All·Age: 18 - 80
Code: NCT07271186·Phase 2·Recruiting